Timothy Miller, Washington University School of Medicine (IMAGE)
Caption
Timothy M. Miller, MD, PhD, of Washington University School of Medicine in St. Louis, is the principal investigator of a clinical trial that found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in people with an inherited form of amyotrophic lateral sclerosis, or ALS, caused by mutations in the gene SOD1.
Credit
Huy Mach
Usage Restrictions
This image is to be used in accordance with the mission, policies and guidelines of Washington University in St. Louis. Visit https://wustl.edu/about/compliance-policies/media-policies/photo-use/ for more information.
License
Licensed content